Novel Therapeutic Strategy in the Treatment of Diabetes Type 2, the Use of Autologous Peripheral Blood Stem Cells in 15 Patients: Is There Any Relation with the Incretin-GLP-1/GIP Axis?
Ciro Gargiulo, Van H. Pham, Tao D. Huynh, Vo L. H. Trieu, Nguyen C. D. Kieu, Melvin Shiffman, Mark J. Holterman, Sergey K. Aityan & Luis Filgueira · Journal of Advances in Medicine and Medical Research · 2017
Peripheral blood stem cells (PB-SCs) are probably the most common and the most “slighted” stem cells utilized in medicine, their clinical application is back to year 1986 with the intent of replacing BM as a stem-cell source. This brief manuscript provides a general view into the...
Open access
Research Article
10.9734/BJMMR/2017/32206